| Popis: |
IntroductionSARS-CoV-2 is spreading rapidly worldwide these days so that it has infected people in many countries. It is a zoonotic virus and the cause of COVID-19 infectious pneumonia. The World Health Organization (WHO) declared it a pandemic on January 30, 2020. Given that no standard treatment has been found for the new coronavirus so far, the present study seeks a way to reduce the incidence and severity of the disease along with health protocols. Some of the factors possibly effective in getting less infected by the SARS-CoV-2 are|taking medication supplements such as zinc, calcium, and vitamin D.Materials and methodsThis cross-sectional study was conducted from May 13 to May 30, 2020, on 93 COVID-19 patients admitted to Khatam Al-Anbia Hospital in Shushtar in southwestern Iran. Some patients' laboratory and clinical of were collected and analyzed using the Chi-squared test, the independent t-test, the Kruskal-Wallis test, and the Spearman rank-order correlation coefficient by IBM SPSS Statistics 18.0 software.FindingsThe severity of the disease (40%) of 37 patients was severe in pulmonary involvement. Serum levels of vitamin D and zinc were lower than the average in all patients. Still, the severity of COVID-19 in patients was not significantly different from their zinc serum levels (P = 0.216). Serum vitamin D was not significantly different (P = 0.102). The severity of COVID-19 in patients was significantly different according to serum calcium levels (P = 0.005). The lower the calcium level, the more severe the disease.ConclusionGiven that the supplementation's effect in preventing COVID-19 has not been confirmed and no study has been published on the appropriate dose of these supplements in COVID-19, taking economically viable calcium-rich food sources, including dairy, is recommended. |
